Cynvenio Biosystems

Cynvenio Biosystems is a molecular diagnostics company that involves in the early detection and treatment of cancer.

Cynvenio Biosystems, Inc. is a molecular diagnostics company dedicated to the early detection and targeted treatment of cancer. Cynvenio has developed and deployed the LiquidBiopsy system to enable realtime monitoring of tumor cell-associated mutations from a simple blood draw. This information can be used by physicians, academic centers, and drug developers to define treatment cycles for individual patients, efficiently select patients for drug trials and monitor patient response at any stage of disease. Cynvenio’s CLIA service lab is based in Westlake Village, California. To find out more about the company please visit: www.cynvenio.com and www.liquidbiopsy.com.